Director of the Africa Centers for Disease Control and Prevention John and Kanga Song said the A U will target it's using countries that have not reported cases of the variant dominance in South Africa.

For countries that have not reported this situation of the South up to billion, that is the end 51 Why be two variants?

We recommend that we proceed with the rollout off as the AstraZeneca vaccine for countries that have reported the situation of the SASK off to variant.

We recommend the acceleration of your preparedness to introduce all Alvar vaccines that have received emergency use, authorization or approval by the regulatory authorities.

Consideration should be given to the effectiveness off the vaccine against the variant that is the end by poor one the A V two variants.

He added that only six countries other than South Africa had reported that the variant was circulating and that more work was needed to understand how the vaccine worked against the more contagious variant.

The comments come after South Africa paused the rollout of the AstraZeneca shot after preliminary trial data showed it offered minimal protection against mild to moderate disease caused by the variant.